TFXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

TELEFLEX INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$129.68−0.75 (-0.58%)

Close on Oct 19, 2026

Market cap: $5.66B
P/E (TTM): –
Dividend yield: 1.05%

Fundamental chart

Pick a measure to chart its full history

$1.99BFY2025, +2.1% a year since FY2011

Where these numbers come from

Parsed from the XBRL in Teleflex's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Jun 17, 1997
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TFX.

Revenue growth30.7% · median 1.6%

Gross margin54.9% · median 52.5%

Operating margin2.0% · median 11.9%

Net margin-45.8% · median 7.1%

Company	Revenue	Growth
TFX	$2.25B	+30.7%
ICUI	$2.16B	-9.0%
IART	$1.65B	+1.6%
MMSI	$1.58B	+10.2%
PEN	$1.50B	+17.6%
HAE	$1.35B	+0.4%

Company

Next earnings (est.): Nov 5, 2026, before open
Exchange: NYSE
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 15,500
Held by institutions: 100.0%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 96943

Advertisement
300 × 250